Skip to main content
. 2014 Aug 27;13:139. doi: 10.1186/1476-511X-13-139

Table 3.

Breast cancer patients’ symptoms scores as measured by the EORTC QLQ-C30* (n = 60, 30 in each group)

Symptom 1st Chemotherapy cycle mean score (SD) 3rd Chemotherapy cycle mean score (SD) 4th Chemotherapy cycle mean score (SD) 5th Chemotherapy cycle mean score (SD) 6th Chemotherapy cycle mean score (SD)
Intervention Control Intervention Control Intervention Control Intervention Control Intervention Control
Fatigue 49.34 36.38 44.26 39.93 46.06 40.56 45.44 41.71 45.88 47.26
(22.75) (24.50) (11.69) (22.94) (13.77) (15.76) (15.29) (15.59) (16.10) (17.58)
Nausea and vomiting 31.19 24.13 36.03 28.73 30.10 26.55 30.11 33.91 30.64 39.08
(25.38) (25.03) (24.02) (28.48) (18.95) (20.53) (20.82) (23.35) (21.98) (31.89)
Pain 34.03 28.16 34.97 29.87 37.09 29.30 34.40 64.35 34.94 41.95
(23.34) (26.39) (16.86) (21.07) (17.05) (21.66) (18.72) (148.92) (20.35) (20.72)
Dyspnoea 22.57 14.94 21.51 12.63 11.49 15.58 18.82 19.53 18.29 20.68
(26.37) (23.30) (25.17) (18.71) (18.72) (18.41) (23.88) (22.74) (25.61) (24.26)
Sleep difficulties 36.55 24.12 38.73 26.42 37.09 33.32 33.86 35.61 31.71 39.06
(26.33) (30.73) (24.50) (27.29) (22.67) (28.18) (22.16) (23.47) (25.23) (21.96)
Loss of appetite 50.53 33.35 49.47 44.25 48.91 43.68 41.38 43.66 40.85 44.82
(33.20) (30.88) (27.05) (31.60) (19.72) (25.38) (23.14) (23.76) (23.52) (32.47)
Constipation 31.16 28.75 37.64 25.28 38.16 24.14 38.70 34.47 40.86 41.38
(27.12) (35.34) (23.38) (27.69) (19.83) (28.05) (24.50) (30.20) (26.83) (31.71)
Diarrhoea 12.90 10.34 17.22 11.49 17.19 16.09 19.34 17.23 26.86 20.69
(20.50) (20.13) (22.57) (20.46) (20.84) (22.92) (22.39) (22.92) (59.83) (27.34)
Financial difficulties 32.25 26.43 25.81 28.73 33.33 27.58 36.56 31.02 37.62 34.48
(31.61) (30.06) (25.40) (31.78) (31.04) (30.95) (29.01) (29.46) (29.50) (31.48)

*A higher value indicates a higher level of functioning and quality of life: min: 0, max: 100.

**Significant different significant difference between intervention and control groups, P < 0.01;

Independent t-test.